Mechanisms of Bortezomib-induced Peripheral Neuropathy

硼替佐米诱发周围神经病变的机制

基本信息

  • 批准号:
    8350911
  • 负责人:
  • 金额:
    $ 14.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-04 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chemotherapy-induced peripheral neuropathy (CIPN) is a serious side-effect arising in ~400,000 cancer patients yearly and often limits chemotherapy dosage. Pain and other quality of life impairments caused by CIPN are increasing as many forms of cancer become chronic conditions, with an estimated annual cost of ~$2.5 billion dollars (NCI Directors Consensus Workshop, June 2011). It has been assumed that as target-specific therapies were discovered, the off-target effect of peripheral neuropathy would lessen. However, as specific mechanism-based therapies (e.g. proteasome and Jak-2 inhibitors) have been introduced, the incidence of painful, chronic neuropathy has persisted at 30-40% of treated patients. Approaches to limit the impact of CIPN include prevention and symptomatic treatment of neuropathic pain. Preventive strategies are complicated by the risk that protection from CIPN may reduce the primary cancer cell killing effect of a drug. Symptomatic treatments for pain are frequently not successful, reflecting a lack of understanding of the underpinnings of neuropathic pain. In this application, the candidate proposes a comprehensive strategy to understand the biological mechanisms of CIPN caused by a specific chemotherapeutic drug (bortezomib) and the physiologic mechanisms underlying pain caused by the drug. The studies are expected to have broader implications for other diseases of the peripheral nervous system. The candidate is an M.D./Ph.D.-trained neurologist with advanced clinical training in peripheral nerve disorders whose career goal is to perform mechanistic and translational investigations of peripheral nerve disorders and neuropathic pain. Chemotherapy-induced peripheral neuropathy will be used as the model disease system to achieve this goal. The career development plan will be mentored by Dr. Anthony Windebank, a neuromuscular physician-scientist with expertise in CIPN, and Dr. Gianrico Farrugia whose lab focuses on structure-function studies of voltage-gated ion channels. The career development plan combines the strengths of the candidate, the mentors, and the research institution in order to provide an opportunity for the candidate to become a successful independent investigator of peripheral nerve disorders.
描述(由申请人提供):化疗诱导的周围神经病变(CIPN)是一种严重的副作用,每年约有40万例癌症患者出现,通常会限制化疗剂量。随着许多形式的癌症变成慢性病症,由CIPN引起的疼痛和其他生活质量损害正在增加,估计每年花费约25亿美元(NCI董事共识研讨会,2011年6月)。据推测,随着靶向特异性治疗的发现,周围神经病变的脱靶效应将减少。然而,随着基于特定机制的治疗(例如蛋白酶体和Jak-2抑制剂)的引入,疼痛性慢性神经病变的发生率在30-40%的治疗患者中持续存在。限制CIPN影响的方法包括预防和对症治疗神经性疼痛。预防策略因CIPN保护可能降低药物的原发性癌细胞杀伤作用的风险而复杂化。疼痛的对症治疗往往不成功,反映出对神经性疼痛的基础缺乏了解。在这项申请中,候选人提出了一个全面的策略,以了解由特定的化疗药物(硼替佐米)引起的CIPN的生物学机制和由药物引起的疼痛的生理机制。预计这些研究将对其他周围神经系统疾病产生更广泛的影响。候选人是医学博士/博士学位-接受过周围神经疾病高级临床培训的神经科医生,其职业目标是对周围神经疾病和神经性疼痛进行机械和转化研究。化疗诱导的周围神经病变将被用作模型疾病系统,以实现这一目标。职业发展计划将由Anthony Windebank博士和Gianrico Farrugia博士指导,Anthony Windebank博士是一位在CIPN方面具有专业知识的神经肌肉医生科学家,Gianrico Farrugia博士的实验室专注于电压门控离子通道的结构功能研究。职业发展计划结合了候选人,导师和研究机构的优势,以便为候选人提供机会,成为周围神经疾病的成功独立研究者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nathan P Staff其他文献

Nathan P Staff的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nathan P Staff', 18)}}的其他基金

The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 14.44万
  • 项目类别:
PHLPP inhibition and Osteoarthritis-Associated Pain
PHLPP 抑制和骨关节炎相关疼痛
  • 批准号:
    10581073
  • 财政年份:
    2023
  • 资助金额:
    $ 14.44万
  • 项目类别:
Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity
研究 MAP2 在化疗引起的周围神经毒性中的作用
  • 批准号:
    10559108
  • 财政年份:
    2023
  • 资助金额:
    $ 14.44万
  • 项目类别:
Assessment of Chemotherapy-Induced Peripheral Neuropathy Susceptibility Using Patient-derived iPSC Technology
使用患者来源的 iPSC 技术评估化疗引起的周围神经病变的易感性
  • 批准号:
    9763518
  • 财政年份:
    2017
  • 资助金额:
    $ 14.44万
  • 项目类别:
Assessment of Chemotherapy-Induced Peripheral Neuropathy Susceptibility Using Patient-derived iPSC Technology
使用患者来源的 iPSC 技术评估化疗引起的周围神经病变的易感性
  • 批准号:
    9450944
  • 财政年份:
    2017
  • 资助金额:
    $ 14.44万
  • 项目类别:
Mechanisms of Bortezomib-induced Peripheral Neuropathy
硼替佐米诱发周围神经病变的机制
  • 批准号:
    9093719
  • 财政年份:
    2012
  • 资助金额:
    $ 14.44万
  • 项目类别:
Mechanisms of Bortezomib-induced Peripheral Neuropathy
硼替佐米诱发周围神经病变的机制
  • 批准号:
    8505004
  • 财政年份:
    2012
  • 资助金额:
    $ 14.44万
  • 项目类别:
Mechanisms of Bortezomib-induced Peripheral Neuropathy
硼替佐米诱发周围神经病变的机制
  • 批准号:
    8677584
  • 财政年份:
    2012
  • 资助金额:
    $ 14.44万
  • 项目类别:
Dopaminergic modulation of CA1 intrinsic excitability
CA1 内在兴奋性的多巴胺能调节
  • 批准号:
    6634372
  • 财政年份:
    2002
  • 资助金额:
    $ 14.44万
  • 项目类别:
Dopaminergic modulation of CA1 intrinsic excitability
CA1 内在兴奋性的多巴胺能调节
  • 批准号:
    6719028
  • 财政年份:
    2002
  • 资助金额:
    $ 14.44万
  • 项目类别:

相似海外基金

Targeting axonal transport regulation by neurotrophic factors to treat peripheral nerve degeneration
通过神经营养因子调节轴突运输来治疗周围神经变性
  • 批准号:
    MR/Y010949/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.44万
  • 项目类别:
    Fellowship
Role of retrograde signaling coupled with anterograde axonal transport in neuronal morphology and its medical applications
逆行信号传导与顺行轴突运输在神经元形态中的作用及其医学应用
  • 批准号:
    23K06814
  • 财政年份:
    2023
  • 资助金额:
    $ 14.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Researches on axonal transport by motor proteins based on force measurements by using nano-spring and non-equilibrium statistical physics
基于纳米弹簧和非平衡统计物理力测量的运动蛋白轴突运输研究
  • 批准号:
    23H02442
  • 财政年份:
    2023
  • 资助金额:
    $ 14.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Transsynaptic control of axonal transport in presynaptic assembly and function
突触前组装和功能中轴突运输的跨突触控制
  • 批准号:
    468356
  • 财政年份:
    2022
  • 资助金额:
    $ 14.44万
  • 项目类别:
    Operating Grants
Analysis of multiple mechanisms of APP axonal transport
APP轴突运输的多种机制分析
  • 批准号:
    22K15270
  • 财政年份:
    2022
  • 资助金额:
    $ 14.44万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The huntingtin protein and its role in axonal transport
亨廷顿蛋白及其在轴突运输中的作用
  • 批准号:
    572842-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 14.44万
  • 项目类别:
    University Undergraduate Student Research Awards
Unravelling the functions of Peptidyl-Prolyl Isomerase A in axonal transport and neuromuscular junction development and maintenance.
揭示肽基脯氨酰异构酶 A 在轴突运输和神经肌肉接头发育和维护中的功能。
  • 批准号:
    RGPIN-2021-03394
  • 财政年份:
    2022
  • 资助金额:
    $ 14.44万
  • 项目类别:
    Discovery Grants Program - Individual
S-acylation dependent regulation of fast axonal transport in neurons
神经元快速轴突运输的 S-酰化依赖性调节
  • 批准号:
    RGPIN-2021-02547
  • 财政年份:
    2022
  • 资助金额:
    $ 14.44万
  • 项目类别:
    Discovery Grants Program - Individual
S-acylation dependent regulation of fast axonal transport in neurons
神经元快速轴突运输的 S-酰化依赖性调节
  • 批准号:
    RGPIN-2021-02547
  • 财政年份:
    2021
  • 资助金额:
    $ 14.44万
  • 项目类别:
    Discovery Grants Program - Individual
Unravelling the functions of Peptidyl-Prolyl Isomerase A in axonal transport and neuromuscular junction development and maintenance.
揭示肽基脯氨酰异构酶 A 在轴突运输和神经肌肉接头发育和维护中的功能。
  • 批准号:
    DGECR-2021-00341
  • 财政年份:
    2021
  • 资助金额:
    $ 14.44万
  • 项目类别:
    Discovery Launch Supplement
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了